3Vote!
Forex Analytics (Free subscription) | 11/16/2009
Drug maker Bristol-Myers Squibb Co. (BMY) said Sunday it will split off its 83.1% holdings in Enfamil baby formula maker Mead Johnson Nutrition Co. (MJN) as a final step towards spinning it off into a fully independent BioPharma company. Bristol-Myers now intends to focus on its core BioPharma business following the split-off. The split-off is [...] Post from: (c)Autor: Forex Analytics ...
3Vote!
Forex Analytics (Free subscription) | 11/16/2009
Drug maker Bristol-Myers Squibb Co. (BMY) said Sunday it will Split off its 83.1% holdings in Enfamil baby formulated maker Mead Johnson Nutrition Co. (MJN) ace has final step towards spinning it off into has fully independent BioPharma company. Bristol-board-Myers now intends to x-ray one its core BioPharma business following the Split-off. The Split-off is [...] Post from: (c)Autor: Forex...
5Vote!
The Wall Street Journal (Free subscription) | 11/16/2009
Bristol-Myers Squibb aid it is moving to split off its nutritionals business in a deal valued at up to about $6.5 billion, an unusual bid to focus the drug maker on its core medicine business.
3Vote!
thepharmaletter.com (Free subscription) | 11/11/2009
Drug major Bristol-Myers Squibb Co. and Alder Biopharmaceuticals has entered into an agreement with Alder Biopharmaceuticals for the development and commercialization of ALD518, a novel biologic that has completed Phase IIa development for the treatment of rheumatoid arthritis, which could net the latter as much as $1 billion.
5Vote!
The Puget Sound Business Journal (Free subscription) | 11/10/2009
Alder Biopharmaceuticals Inc. said it’s signed a deal with Bristol-Myers Squibb Co. to commercialize the Bothell biotech’s rheumatoid arthritis drug. (BMY)
6Vote!
Reuters (Free subscription) | 12/01/2009
... an order filed on Monday in Manhattan federal court.Wood granted the U.S. Securities and Exchange Commission's motion for a default judgment. The civil fine equals 1-1/2 times Anticevic's estimated ill-gotten gains, which totaled nearly $2.06 million. The SEC had sought a treble fine.The case first surfaced in 2005, and is one of the more unusual insider trading cases in recent years.It included...
3Vote!
Health - The Post Chronicle (Free subscription) | 11/30/2009
The World Health Organization (WHO) on Monday issued revised guidelines for millions of people infected with HIV, the virus that causes AIDS.Here are the major recommendations by the United Nations agency which has 193 member states:* Countries should phase out use of Stavudine, the most widespread antiretroviral, because it has "long-term, irreversible" side-effects including wasting and a nerve disorder.U.S....
3Vote!
Reuters UK (Free subscription) | 11/30/2009
... of the virus that causes AIDS.Stavudine, also known as d4T, is marketed as Zerit by U.S. drugmaker Bristol-Myers Squibb Co. Generic versions are made by Cipla Ltd, Aurobindo Pharma Ltd and Strides Arcolab Ltd, all of India.Stavudine, widely available in developing countries as a first-line therapy, is relatively cheap and easy to use, according to the United Nations agency.But it causes...
+Vote!
Seattle Post-Intelligencer (Free subscription) | 11/23/2009
NEW YORK -- Drugmaker Bristol-Myers Squibb Co. and Asterand PLC are extending a research collaboration for up to three years, Asterand said Monday.
+Vote!
Miami Herald (Free subscription) | 11/23/2009
Drugmaker Bristol-Myers Squibb Co. and Asterand PLC are extending a research collaboration for up to three years, Asterand said Monday.
5Vote!
SeekingAlpha.com (Free subscription) | 11/23/2009
Zacks.com submits: Recently, Bristol-Myers Squibb Co. ( BMY ) received approval from the U.S. Food and Drug Administration (FDA) to market Abilify (aripiprazole) for the treatment of irritability in pediatric patients having autistic disorder. Abilify can be used to treat children aged 6 to 17 years for symptoms of aggression toward others, deliberate self injury, temper tantrums and quick...
3Vote!
Reuters UK (Free subscription) | 11/17/2009
WASHINGTON (Reuters) - Common heartburn pills Prilosec and Nexium cut the blood-thinning effect of Sanofi-Aventis SA's and Bristol-Myers Squibb Co's heart drug Plavix, U.S. officials warned on Tuesday.
